Medical Device Developments Weekly

Medical Device Developments Weekly

Welcome to this week's Medical Device Developments newsletter.

See the latest insight and analysis from the global medical device market from the last week below:


Ventris Medical wins second FDA clearance for Amplify Standalone Bone Graft Putty

?? Ventris Medical wins second FDA clearance for Amplify Standalone Bone Graft Putty  Amplify is a new class of synthetic biomaterials specifically engineered to optimise bone production and cell proliferation.  The synthetic bone graft putty is made using Amplify biphasic (HA/βTCP) ceramic granules suspended in an alkylene oxide polymer carrier.  According to Ventris Medical, the device can be used as a bone graft extender alone or in conjunction with autograft bone at a 1:1 ratio.  Ventris Medical CEO Russell Cook said: “We are very pleased to receive FDA clearance for Amplify Synthetic Bone Graft Putty for the intervertebral disc space.  “This technology combines two heavily studied biphasic mineral components which are surface activated through our patented process and suspended in our proprietary polymer carrier.  “In a market crowded with a plethora of commodity offerings, our company mission is to develop next generational devices that bring excitement to the surgeon community as well as our distribution partners.”  The orthobiologics company received its first FDA clearance for Amplify bone graft putty in September 2022, for its use as a bone graft extender.  To increase remodelling potential, Amplify granules undergo a unique surface activation method to a network of polygonal microfilaments.  Read more online: https://lnkd.in/eSAnzhar  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  #MedicalDeviceDevelopments #ventrismedical #bonegraft

Amplify is a new class of synthetic biomaterials specifically engineered to optimise bone production and cell proliferation.

The synthetic bone graft putty is made using Amplify biphasic (HA/βTCP) ceramic granules suspended in an alkylene oxide polymer carrier.

According to Ventris Medical, the device can be used as a bone graft extender alone or in conjunction with autograft bone at a 1:1 ratio.

To increase remodelling potential, Amplify granules undergo a unique surface activation method to a network of polygonal microfilaments.

Read more


DW Healthcare Partners divests dermoscopy tools maker DermLite to FotoFinder Systems GmbH

?? DW Healthcare Partners divests dermoscopy tools maker DermLite to FotoFinder Systems GmbH  DermLite, which is based in California, is a portfolio company of DW Healthcare Partners’ Founders Fund.  It develops handheld dermoscopy solutions for use by dermatologists and other healthcare professionals.  These solutions include dermatoscopes and phone adapters that use LED lights and magnification lenses to help the trained eye identify skin cancer and other skin diseases.  DermLite chief product officer Thorsten Trotzenberg said: “We would like to thank the team at DWHP for their support over the last three years.  “They have been excellent partners and have made significant contributions to the continued growth and success at DermLite.”  FotoFinder Systems GmbH said that the acquisition will enable it to combine DermLite’s expertise in dermatoscope technology with the company’s advanced imaging systems.  The combined group is anticipated to provide a wide range of goods and services for cutting-edge dermatological research and diagnostics.  Customers will have access to an entire ecosystem of skin imaging tools, powered by state-of-the-art artificial intelligence (AI), ranging from handheld devices to whole body dermoscopy systems.  FotoFinder Systems GmbH CEO Andreas Mayer said: “We’re excited to welcome DermLite to the FotoFinder family.  “This union represents a significant step in our mission to facilitate early detection and accurate diagnosis of skin cancer worldwide.  Our shared vision is to provide our customers with everything they need for skin imaging under one roof.”  Read more online: https://lnkd.in/eZFUkmPs  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  #MedicalDeviceDevelopments

DermLite, which is based in California, is a portfolio company of DW Healthcare Partners’ Founders Fund.

It develops handheld dermoscopy solutions for use by dermatologists and other healthcare professionals.

These solutions include dermatoscopes and phone adapters that use LED lights and magnification lenses to help the trained eye identify skin cancer and other skin diseases.

FotoFinder Systems GmbH said that the acquisition will enable it to combine DermLite’s expertise in dermatoscope technology with the company’s advanced imaging systems.

Read more


Philips taps Amazon Web Services (AWS) to enable cloud-based digital pathology solutions

?? Philips taps Amazon Web Services (AWS) to enable cloud-based digital pathology solutions  The collaboration combines Philips’ expertise in digitisation of pathology to optimise clinical workflows and AWS’ secure and scalable cloud solutions.  It will advance digital pathology and help pathology labs store, manage, and analyse digital pathology data and help more pathology labs adopt digital workflows to enhance productivity.  Also, the collaboration will help pathology labs optimise workflow and, enable effortless integration with existing healthcare systems to deliver holistic patient care.  Philips will use AWS’ HealthImaging solution to optimise storage, enhance the scale and enable AI and research, to advance pathology image analysis and simplify clinical workflows.  In addition, it will benefit from Amazon Bedrock, which offers high-performing foundation models (FMs), for the development and integration of generative AI applications.  Read more online: https://lnkd.in/eUEha6Wk  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  #MedicalDeviceDevelopments #medicaldevicemanufacturing #pathology

The collaboration combines Philips’ expertise in digitisation of pathology to optimise clinical workflows and AWS’ secure and scalable cloud solutions.

It will advance digital pathology and help pathology labs store, manage, and analyse digital pathology data and help more pathology labs adopt digital workflows to enhance productivity.

Also, the collaboration will help pathology labs optimise workflow and, enable effortless integration with existing healthcare systems to deliver holistic patient care.

Read more


Medical Device Developments The medical device and diagnostic industry is currently valued at over $350bn. Technological advances in medical device and diagnostics design are driven by an increasingly demanding market and legislative requirements. A growing patient population and a worldwide governmental drive towards preventive therapies are also fuelling the development of innovative devices. Medical Device Developments is published in response to the increasing information needs of the major global medical device manufacturers/OEMs. The publication, which is published biannually, will incorporate authoritative reviews of current trends and emerging technologies, and provide the industry’s decision-makers with clear, concise and unbiased technical articles and case histories on cutting-edge developments, products and applications, drawing on the expertise of leading engineers and designers from around the globe.

Welldoc secures CE mark approval for BlueStar mobile app

????? Welldoc secures CE mark approval for BlueStar mobile app  BlueStar is an FDA-approved digital health solution that guides individuals through the complicated journey of living with diabetes.  The mobile app enables patients living with diabetes to self-manage their care while improving connections with their healthcare team.  The CE mark approval allows the digital health company and its strategic partners to advance digital health solutions in the EU, addressing growing chronic condition needs.  The EU approval builds upon Welldoc’s existing 11 FDA approvals for type 1 and type 2 diabetes management capabilities, including advanced insulin dosing calculators.  Read more online: https://lnkd.in/eUDPvKnE  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  #MedicalDeviceDevelopments #diabetes #remotehealthcare

BlueStar is an FDA-approved digital health solution that guides individuals through the complicated journey of living with diabetes.

The mobile app enables patients living with diabetes to self-manage their care while improving connections with their healthcare team.

The CE mark approval allows the digital health company and its strategic partners to advance digital health solutions in the EU, addressing growing chronic condition needs.

Read more


Intuitive secures FDA approval for Da Vinci 5 multiport robotic system

?? Intuitive secures FDA approval for Da Vinci 5 multiport robotic system  Da Vinci 5 is the latest addition to Intuitive’s da Vinci family of robotic surgical systems, which comprises da Vinci X and da Vinci Xi multiport systems, and the da Vinci SP single-port system.  The new device has been designed based on the company’s da Vinci Xi device, which has been used by surgeons and care teams in more than 7 million procedures worldwide.  Intuitive intends to commercialise Da Vinci 5 initially to limited US customers who collaborated with the company during its development and those with mature robotic surgery programs.  The medical device maker intends to work with surgeons at the initial sites to create additional data on the system’s use, prior a wider commercial roll-out.  Intuitive Surgical CEO Gary Guthart said: “Intuitive is committed to meaningful improvements in surgery that enable better patient outcomes, enhance the patient and care team experiences, and ultimately lower the total cost of care.  “After more than a decade of careful research, design, development, and testing, we believe da Vinci 5 will deliver on these goals and help drive the future of robotic-assisted surgery.”  Read more online: https://lnkd.in/gShMvZRq  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  #MedicalDeviceDevelopments #intuitive #surgicalrobotics

Da Vinci 5 is the latest addition to Intuitive’s da Vinci family of robotic surgical systems, which comprises da Vinci X and da Vinci Xi multiport systems, and the da Vinci SP single-port system.

The new device has been designed based on the company’s da Vinci Xi device, which has been used by surgeons and care teams in more than 7 million procedures worldwide.

Intuitive intends to commercialise Da Vinci 5 initially to limited US customers who collaborated with the company during its development and those with mature robotic surgery programs.

Read more


J&J MedTech and NVIDIA forge partnership to drive AI applications in surgery

????? Johnson & Johnson MedTech and NVIDIA forge partnership to drive AI applications in surgery  The partnership is intended to bolster access to real-time analysis and the worldwide availability of AI algorithms.  These applications will be used for surgical decision-making, training, and collaboration across the connected operating room (OR).  Johnson & Johnson MedTech will combine its surgical technologies portfolio with NVIDIA’s healthcare-focused AI platform.  The medical technology firm said that these technologies will enable rapid, secure, and real-time deployment of AI using its connected digital ecosystem for surgery.  Under the collaboration, Johnson & Johnson MedTech will combine its digital ecosystem with the NVIDIA IGX edge computing platform and NVIDIA Holoscan edge AI platform.  The American medical technology firm will create infrastructure to deploy these AI-driven software algorithms for surgery in the OR.  NVIDIA said that IGX and Holoscan can aid in secure, real-time processing of data from devices across the OR to offer clinical insights and enhance surgical outcomes.  Johnson & Johnson MedTech executive vice president and worldwide chairman Tim Schmid said: “Johnson & Johnson MedTech is advancing healthcare toward a future that’s more connected and personalised.  “This future will be increasingly enabled by digital technologies that deliver efficiency, inform decision-making, and extend surgical training and education.  “Our deep heritage in healthcare and digital ecosystem in surgery and NVIDIA’s AI platforms hold enormous potential to create a more connected surgical experience.”  Read more online: https://lnkd.in/eZbkxVRW  ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter  hashtag#MedicalDeviceDevelopments hashtag#johnsonandjohnson hashtag#nvidia hashtag#ai

The partnership is intended to bolster access to real-time analysis and the worldwide availability of AI algorithms.

These applications will be used for surgical decision-making, training, and collaboration across the connected operating room (OR).

J&J MedTech will combine its surgical technologies portfolio with NVIDIA’s healthcare-focused AI platform.

The medical technology firm said that these technologies will enable rapid, secure, and real-time deployment of AI using its connected digital ecosystem for surgery.

Read more


Bringing together experts from a variety of industries for face-to-face and virtual events, diner clubs and conferences

Upcoming webinars

Recommended webinars


Thanks for reading; we hope you enjoyed it.

Until next week.

To have a story featured on next week's newsletter - contact Medical Device Developments or Martin John directly.

#MedicalDeviceDevelopments

要查看或添加评论,请登录

社区洞察

其他会员也浏览了